AtriCure to Present at the JMP Securities Life Science Conference
MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will present at the JMP Securities Life Science Conference at the St. Regis Hotel in New York City on Tuesday, June 20, 2017. Management is scheduled to present at 3:30 p.m. Eastern Time. A live audio webcast of the presentation may be accessed by visiting the Investors page of AtriCure’s corporate website at ir.atricure.com. A replay of the presentation will be available for 90 days following the presentation.
About AtriCure
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 100,000 implanted to date. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170518005092/en/
AtriCure, Inc.
Andy Wade, 513-755-4564
Senior Vice President
and Chief Financial Officer
[email protected]
or
Gilmartin
Group
Lynn Pieper Lewis, 415-937-5402
Investor Relations
[email protected]
Source: AtriCure, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Guardant Health receives FDA approval for companion diagnostic test
- Pilgrim’s Announces Investment in Ellijay, Georgia to Strengthen Operations and Align With Growing Consumer Demand
- Eight Saints Launches Firm Intentions, a Clean Anti-Aging Neck Cream, Targeting Skincare's Most Overlooked Area
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
JMP Securities, Twitter, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share